• LAST PRICE
    21.96
  • TODAY'S CHANGE (%)
    Trending Up0.10 (0.46%)
  • Bid / Lots
    21.88/ 2
  • Ask / Lots
    21.94/ 2
  • Open / Previous Close
    21.93 / 21.86
  • Day Range
    Low 21.93
    High 21.96
  • 52 Week Range
    Low 19.32
    High 22.45
  • Volume
    1,870
    below average
  • Overall Morningstar Rating
    Please Note: Not Ratedout of funds

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 21.84
TimeVolumeLIFE
10:57 ET30021.93
12:20 ET40021.94
02:06 ET100021.93
03:43 ET10021.96
Data delayed at least 15 minutes.
Asset Class
Asset Class
US Equity
76.3%
Int'l Equity
23.2%
Cash
0.5%
CDN Equity
0
Fixed Income
0
Other
0
Sectors
Sectors
Healthcare100.1%
Basic Mat.0
Communication Services0
Consumer Cyclical0
Consumer Defensive0
Energy0
Financial Serv.s0
Industrials0
Real Estate0
Technology0
Utilities0
Geographic Region
Geographic Region
United States
76.2%
Europe
4.5%
Latin America
0
Africa
0
Canada
0
Asia/Oceania
0
As of 2024-02-29
Top 10 Holdings
Company Name sortablePosition sortableAllocation sortable
Allocation
1 Month Change
sortable
Market Value sortable
United StatesLLY
Eli Lilly and Co
Long
5.8%
-41.39%
$16.5M
United StatesDHR
Danaher Corp
Long
5.6%
+27.20%
$15.9M
United StatesNVO
Novo Nordisk A/S ADR
Long
5.6%
+35.85%
$15.8M
United StatesSYK
Stryker Corp
Long
5.6%
-13.05%
$15.7M
United StatesABBV
AbbVie Inc
Long
5.4%
-1.46%
$15.3M
United StatesMRK
Merck & Co Inc
Long
5.3%
-1.29%
$15.1M
United StatesISRG
Intuitive Surgical Inc
Long
5.3%
---
$14.9M
United StatesTMO
Thermo Fisher Scientific Inc
Long
5.2%
+12.22%
$14.8M
United StatesABT
Abbott Laboratories
Long
5.2%
+3.94%
$14.7M
United StatesBMY
Bristol-Myers Squibb Co
Long
5.0%
+50.70%
$14.2M
As of 2024-03-28

Reports

No reports available

Morningstar Ratings

Morningstar Ratings Table
Time HorizonStar Rating
Overall RatingPlease Note: Not Rated
3 Year RatingPlease Note: Not Rated
5 Year RatingPlease Note: Not Rated
10 Year RatingPlease Note: Not Rated
As of 2024-02-29

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

ETF Profile
Best Fit Index
---
Category
Sector Equity
Sponsor
Evolve Funds Group Inc
Inception
October 23, 2017
As of 2024-02-29

LIFE seeks to replicate, to the extent reasonably possible before fees and expenses, the performance of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged, or any successor thereto, while mitigating downside risk. LIFE invests primarily in the equity constituents of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged, or any successor thereto, while writing covered call options on up to 33% of the portfolio securities, at the discretion of the Manager. The level of covered call option writing may vary based on market volatility and other factors.

Holding Details
Total Net Assets$194.5M
Shares Out.9.0M
Net Asset Value (NAV)$21.87
Prem/Discount to NAV-0.15%
P/E Ratio30.6
Dividend Yield8.74%
Dividend per Share1.92 CAD
Ex-Dividend Date03/27/2024
Dividend Payment Date04/8/2024
Beta---
Morningstar Investment StyleSector Equity
Equity Style
Large Cap Blend
Credit Quality / Duration
---
Fees & Expenses
Actual Management Fee0.45%
Actual Mgmt. Expense Ratio (MER)0.68%